BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15168591)

  • 1. Alterations of common chromosome fragile sites in hematopoietic malignancies.
    Ishii H; Furukawa Y
    Int J Hematol; 2004 Apr; 79(3):238-42. PubMed ID: 15168591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
    Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
    Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common fragile sites and cancer (review).
    Smith DI; Huang H; Wang L
    Int J Oncol; 1998 Jan; 12(1):187-96. PubMed ID: 9454904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel approach to simultaneously scan genes at fragile sites.
    Willem P; Brown J; Schouten J
    BMC Cancer; 2006 Aug; 6():205. PubMed ID: 16895604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of exogenous E2F-1 on the expression of common chromosome fragile site genes, FHIT and WWOX.
    Ishii H; Mimori K; Vecchione A; Sutheesophon K; Fujiwara T; Mori M; Furukawa Y
    Biochem Biophys Res Commun; 2004 Apr; 316(4):1088-93. PubMed ID: 15044096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines.
    Ong ST; Fong KM; Bader SA; Minna JD; Le Beau MM; McKeithan TW; Rassool FV
    Genes Chromosomes Cancer; 1997 Sep; 20(1):16-23. PubMed ID: 9290949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of FRAXB and comparative common fragile site instability in cancer cells.
    Arlt MF; Miller DE; Beer DG; Glover TW
    Genes Chromosomes Cancer; 2002 Jan; 33(1):82-92. PubMed ID: 11746990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
    Corbin S; Neilly ME; Espinosa R; Davis EM; McKeithan TW; Le Beau MM
    Cancer Res; 2002 Jun; 62(12):3477-84. PubMed ID: 12067991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of the fragile histidine triad gene early in carcinogenesis: an update.
    Ishii H; Ozawa K; Furukawa Y
    J Exp Ther Oncol; 2003; 3(6):291-6. PubMed ID: 14678517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common chromosome fragile sites in human and murine epithelial cells and FHIT/FRA3B loss-induced global genome instability.
    Hosseini SA; Horton S; Saldivar JC; Miuma S; Stampfer MR; Heerema NA; Huebner K
    Genes Chromosomes Cancer; 2013 Nov; 52(11):1017-29. PubMed ID: 23929738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common fragile genes and digestive tract cancers.
    Kuroki T; Tajima Y; Furui J; Kanematsu T
    Surg Today; 2006; 36(1):1-5. PubMed ID: 16378185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of deletions at the FRA3B/FHIT locus in carcinogenesis.
    Huebner K; Druck T; Siprashvili Z; Croce CM; Kovatich A; McCue PA
    Recent Results Cancer Res; 1998; 154():200-15. PubMed ID: 10027001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common fragile sites, extremely large genes, neural development and cancer.
    Smith DI; Zhu Y; McAvoy S; Kuhn R
    Cancer Lett; 2006 Jan; 232(1):48-57. PubMed ID: 16221525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common chromosomal fragile sites and cancer: focus on FRA16D.
    O'Keefe LV; Richards RI
    Cancer Lett; 2006 Jan; 232(1):37-47. PubMed ID: 16242840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of FHIT and WWOX fragile genes in cancer.
    Iliopoulos D; Guler G; Han SY; Druck T; Ottey M; McCorkell KA; Huebner K
    Cancer Lett; 2006 Jan; 232(1):27-36. PubMed ID: 16225988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the FHIT/FRA3B locus in cancer.
    Huebner K; Garrison PN; Barnes LD; Croce CM
    Annu Rev Genet; 1998; 32():7-31. PubMed ID: 9928473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common fragile site tumor suppressor genes and corresponding mouse models of cancer.
    Drusco A; Pekarsky Y; Costinean S; Antenucci A; Conti L; Volinia S; Aqeilan RI; Huebner K; Zanesi N
    J Biomed Biotechnol; 2011; 2011():984505. PubMed ID: 21318118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland.
    Dincer N; Tezel GG; Sungur A; Himmetoglu C; Huebner K; Güler G
    Oral Oncol; 2010 Mar; 46(3):195-9. PubMed ID: 20060354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WWOX: a fragile tumor suppressor.
    Schrock MS; Huebner K
    Exp Biol Med (Maywood); 2015 Mar; 240(3):296-304. PubMed ID: 25538133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of common chromosomal fragile site genes, WWOX/FRA16D and FHIT/FRA3B is downregulated by exposure to environmental carcinogens, UV, and BPDE but not by IR.
    Thavathiru E; Ludes-Meyers JH; MacLeod MC; Aldaz CM
    Mol Carcinog; 2005 Nov; 44(3):174-82. PubMed ID: 16187332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.